Asuragen, Inc., a leader in the development of molecular diagnostics, announced today the appointment of Biomedical Diagnostics SA (BMD), a leading medical diagnostic company in Europe, as its exclusive distributor of Si...
A California Institute of Technology (Caltech)-led team of researchers and clinicians has published the first proof that a targeted nanoparticle-used as an experimental therapeutic and injected directly into a patient's bloodstream-can traffic into tumors, deliver double-stranded small interfering RNAs (siRNAs), and turn off an important cancer gene using a mechanism known as RNA interference (RNAi).
The question of whether or not nanoparticles have an effect on the human body - and if so, how - is still largely unanswered. There is little information, for instance, on whether pregnant women exposed to these minute particles pass them on to their unborn babies.
Using a system of nanofluidic channels and multicolor fluorescence microscopy, a team of investigators at Cornell University has developed a method that analyzes the binding of DNA and DNA-binding proteins known as histo...
Biozentrum researchers have now discovered that Escherichia coli bacteria harness a sophisticated chemosensory and signal transduction machinery that allows them to accurately control motor rotation, thereby adjusting th...
Haemonetics Corporation (NYSE: HAE), a global blood management solutions company, today announced that it has entered into a reagent development and supply agreement with Quotient Biodiagnostics Group and its wholly owne...
Celsense, Inc. announced today its launch of the first off-the-shelf software for merging scanner images.
Researchers in London have found that nanometer size diamonds can be attached to a wide range of substrates and that they can promote the growth of neurons without the need for the complex layers of proteins normally required.
Understanding the steps to the intricate dance inside a cell is essential to one day choreographing the show. By studying the molecules that give a cell its structure, University of Illinois researchers are moving closer to understanding one of those steps: the conga line.
Compugen Ltd. (NASDAQ: CGEN) announced today the development and validation of its Intracellular Drug Delivery (IDD) discovery platform for identification of cell penetrating peptides. Compugen also announced that as par...
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.